Keyphrases
Vaccination
100%
Single-center Experience
100%
Haematopoietic Stem Cell Transplant Recipients
100%
MRNA-1273
100%
SARS-CoV-2 Vaccination
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
60%
COVID-19
40%
Hematopoietic Stem Cell Transplantation
40%
Serological Response
40%
Moderna
20%
High Efficacy
20%
High Mortality Rate
20%
B Lymphocytes
20%
Neutralizing Antibodies
20%
Prospective Observational Study
20%
Adverse Events
20%
Hospitalization
20%
Preventive Strategies
20%
Serological Test
20%
Oncology Patients
20%
Median Range
20%
Lymphocyte Count
20%
Allogeneic
20%
Vaccine Dose
20%
Seroconversion
20%
Two-dose
20%
Hypogammaglobulinemia
20%
Potential Risk Factors
20%
Impaired Immunity
20%
Serological Status
20%
Seroconversion Rate
20%
COVID-19 Vaccination
20%
Vaccination against SARS-CoV-2
20%
Anti-CD20 Therapy
20%
Community Transmission
20%
Severe COVID-19 Disease
20%
Community Deaths
20%
Medicine and Dentistry
COVID-19
100%
Hematopoietic Stem Cell Transplantation
100%
COVID-19 Vaccination
100%
Seroconversion
66%
Autologous Hematopoietic Stem Cell Transplantation
66%
Diseases
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
CD20
33%
Adverse Event
33%
Mortality Rate
33%
Allogeneic Hematopoietic Stem Cell Transplantation
33%
Serological Test
33%
Observational Study
33%
Hypogammaglobulinemia
33%
B Lymphocyte
33%
Neutralizing Antibody
33%
Immunology and Microbiology
COVID-19
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Hematopoietic Stem Cell Transplantation
100%
Seroconversion
50%
Autologous Hematopoietic Stem Cell Transplantation
50%
Neutralizing Antibody
25%
B Cell
25%
CD20
25%
Mortality Rate
25%
Lymphocyte Count
25%
Serology
25%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
Hypogammaglobulinemia
25%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Observational Study
50%
Immunoglobulin Deficiency
50%
Disease
50%
Adverse Event
50%
Mortality Rate
50%
Neutralizing Antibody
50%